1. Home
  2. TXG vs BCRX Comparison

TXG vs BCRX Comparison

Compare TXG & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$21.69

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.26

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
BCRX
Founded
2012
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
TXG
BCRX
Price
$21.69
$9.26
Analyst Decision
Hold
Strong Buy
Analyst Count
15
11
Target Price
$20.25
$20.82
AVG Volume (30 Days)
2.4M
3.5M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
381.40
EPS
N/A
1.21
Revenue
$245,893,000.00
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.33
$12.55
P/E Ratio
N/A
$7.60
Revenue Growth
68.06
N/A
52 Week Low
$7.72
$6.00
52 Week High
$26.45
$11.31

Technical Indicators

Market Signals
Indicator
TXG
BCRX
Relative Strength Index (RSI) 47.90 53.23
Support Level $11.66 $7.99
Resistance Level $23.43 $10.15
Average True Range (ATR) 1.42 0.37
MACD -0.32 -0.03
Stochastic Oscillator 31.02 58.26

Price Performance

Historical Comparison
TXG
BCRX

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: